Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: Effects of cetirizine

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 3, 1997, Pages 341-347

  Zweiman, Burton ^a   Atkins, Paul C ^a   Moskovitz, Anne ^a   Von Allmen, Carolyn ^a   Ciliberti, Michael ^a   Grossman, Scott ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Pfizer Central Research   (United States)

Author keywords

Cetirizine; Cutaneous allergic response; Eosinophil cationic protein; Eosinophils; Lactoferrin; Late phase response; Neutrophils

Indexed keywords

CETIRIZINE;

ALLERGY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; HUMAN; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030799050     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70247-1     Document Type: Article

References (21)

1. Cockroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen induced increase in non-allergic bronchial reactivity. Clin Allergy 1977;7:503-17.
2. Tsicopoulos A, Hamid Q, Haczku A, Jacobson MR, Durham SR, North J, et al. Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individual. J Allergy Clin Immunol 1994;94:764-72.
3. - lymphocytes, activated eosinophils and the magnitude of the allergen induced late cutaneous response in man. J Immunol 1988;141:4158-64.
4. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62:579-89.
5. Fadel R, Herpin-Richard N, Rihoux JP, Henoq E. Inhibitory effect of Cet 2 HCL on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
6. Redier H, Chanez P, De Voss C, Rifai N, Clauzel A-M, Michel F-M, et al. Inhibitory effect of Cet on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
7. Charlesworth EN, Massey WA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-70.
8. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Effect of cetirizine on mast cell mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989;83:905-12.
9. Michel L, de Voss C, Rihoux J-P, Burtin C, Beneviste J, Dubertret L. Inhibitory effect of oral cetirizine on in-vivo antigen induced histamine and PAF-acether release and eosinophil recruitment in normal skin. J Allergy Clin Immunol 1988;82:101-9.
10. Fadel R, David B, Herpin-Richard N, Borgnon A, Rassemont R, Rhioux J-P. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF acetheter) in man. J Allergy Clin Immunol 1990;86:314-20.
11. Wasserfallen JB, Leuenberger P, Pecoud A. Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with antigen. J Allergy Clin Immunol 1993;91:1189-97.
12. Ciprandi G, Buscaglia S, Pesce G, Passalacqua G, Rhioux J-P, Bagnasco M, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD-54) expression on conjunctival epithelium in both early and late-phase reactions after specific antigen challenge. J Allergy Clin Immuno1 1995;95:612-21.
13. Redier H, Chanez P, DeVos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
14. Atkins P, Zweiman B, Moskovitz A, von Allmen C, Valenzano M. Cutaneous late phase inflammatory responses: effects of cetirizine [abstract]. J Allergy Clin Immunol 1995;95:384.
15. Zweiman B, Kuchich U, Shalit M, et al. Release of lactoferrin and clastase in human allergic skin reactions. J Immunol 1990;144:3953-60.
16. Atkins P, Green GR, Zweiman B. Histologic studies of human skin test responses to ragweed, compound 48/80 and histamine. J Allergy Clin Immunol 1973:51:263-73.
17. Slott RI, Zweiman B. Histologic studies of human skin test responses to ragweed and compound 48:80. II. Effect of corticosteroid therapy. J Allergy Clin Immunol 1973;51:263-73.
18. Bierman CW, Maxwell D, Rytina E, Emanuel MB, Lee TH. Effect of H1-receptor blockade on late cutaneous reactions to antigen: a double-blind, controlled study. J Allergy Clin Immunol 1991;87:1013-9.
19. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster, IL3, IL4, IL5 and granulocyte/macrophage colony stimulating factor, in allergen induced late phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-8.
20. Varney V, Gaga M, Frew AJ, De Vos C, Kay AB. The effect of a single oral dose of prednisolone or Cet on inflammatory cells infiltrating allergen induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992;22:43-9.
21. Johnsen FL, Brandzaeg P, Halstensen TS. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J Immunol Method 1994;175:23-36.